Novartis on Friday posted quarterly adjusted net income well above analyst estimates on forecast-beating sales of established ...

Novartis AG said profit will rise this year as new medicines help offset competition from copycats of its best-selling drug, ...

Novartis expects profit and sales to grow further this year after beating analysts' expectations in the fourth quarter, boosted by revenue from its key drugs.

Jefferies analyst Peter Welford maintained a Hold rating on Novartis AG (NOVN – Research Report) today and set a price target of ...

European shares were at a record high on Friday, led by technology and healthcare stocks, even as caution prevailed ahead of ...

The president confirmed his long-threatened tariffs will come into effect on Saturday, and said they “may or may not rise ...